Whitney Egem
Analyst
Canaccord
Equibles does not estimate personal net worth.
About Whitney Egem
Whitney Egem is recorded as Analyst at Canaccord. Whitney Egem has spoken on 4 investor events across 4 companies, most recently for Palvella Therapeutics, Inc. on August 12, 2026. Those appearances were for Palvella Therapeutics, Inc. (PVLA), Wave Life Sciences, Inc. (WVE), Fractyl Health, Inc. (GUTS) and Biomarin Pharmaceutical Inc (BMRN). The companies whose calls Whitney Egem spoke on are classified in the Healthcare sector.
Whitney Egem on recent calls
“I'm one of the biotech analysts here at Canaccord. And it's my pleasure for the last slot of the day to be chatting with Palvela. And as I said, ending on a high note.”
“I'm one of the biotech analysts here at Canaccord, and I'm pleased to be chatting now with Wave Life Sciences and President and CEO Paul Bolno. So thank you so much for being here, Paul.”
“We're going to go ahead and get started. My name is Whitney Egem. I'm one of the biotech analysts here at Canaccord. And I am very pleased to be joined this morning by Fractal Health and CEO Harith Rajagopalan.”
“I'm one of the biotech analysts here at Canaccord, and it's my pleasure to introduce Biomarin Pharmaceutical this morning. And on behalf of Biomarin, we have Brian Mueller, CFO.”
Affiliation history
-
Canaccord
Analyst
Transcript header (unverified)
Current
Company network
Fractyl Health, Inc.
GUTS
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-08-12
View calls and events